Phase 3 Randomized Double-Blind Study of Abemaciclib versus Placebo in Patients with Advanced Dedifferentiated Liposarcoma
Clinical Trial Grant
Administered By
Duke Cancer Institute
Awarded By
Sarcoma Alliance for Research Through Collaboration
Start Date
February 28, 2022
End Date
August 15, 2026
Administered By
Duke Cancer Institute
Awarded By
Sarcoma Alliance for Research Through Collaboration
Start Date
February 28, 2022
End Date
August 15, 2026